文献速递毛发、甲与色素性疾病

常见处方药物与脱发的关联:证据等级综述

Commonly prescribed medications associated with alopecia.
PubMed 文献 · J Am Acad Dermatol · 2023-01-01

该研究通过检索PubMed、Embase和Web of Science,系统回顾了最常处方药物与脱发关联的文献证据等级。共调查192种独特药物,110种有阳性搜索结果,其中13种在强证据等级研究中与脱发相关。作者指出该领域高证据等级研究仍较少,脱发机制需进一步明确。

要点

  • 13种药物在强证据等级研究中与脱发相关,包括阿达木单抗、英夫利西单抗、布地奈德等。
  • 共调查192种独特药物,110种有阳性搜索结果。
  • 作者指出药物相关脱发领域高证据等级研究较少,机制需进一步明确。

核心结论

  • 关于药物相关脱发的高证据等级研究较少,脱发机制需进一步明确以提供有效管理。

研究设计与样本

  • 通过IMS「Top 100 Prescriptions, Sales」和RxList.com「Top 200 Names Searched」编制最常处方药物列表,检索PubMed、Embase和Web of Science中「通用药名」AND「alopecia」及「通用药名」AND「hair loss」,由两名评价者独立审核文章的药物、研究类型与证据等级及脱发病例数。

主要发现

  • 共调查192种独特药物,其中110种产生阳性搜索结果。
  • 13种药物在强证据等级研究中与脱发相关:阿达木单抗、英夫利西单抗、布地奈德、干扰素β-1α、他克莫司、依诺肝素、带状疱疹疫苗、拉莫三嗪、多西他赛、卡培他滨、厄洛替尼、伊马替尼和硼替佐米。

局限性

  • 仅纳入可获取的英文全文文章。
  • 方法学依赖基于销售额而非处方数量的药物列表,可能过度代表昂贵药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis and treatment of medication-associated alopecia often challenges patients and physicians. While numerous studies on the topic exist, limited information on the strength and magnitude of these studies exists. OBJECTIVES: We investigated the most commonly prescribed medications with high levels of evidence to support associations with alopecia. METHODS: A list of most commonly prescribed medications was compiled using the "Top 100 Prescriptions, Sales" (Intercontinental Marketing Services) and "Top 200 Names Searched" (RxList.com). PubMed, Embase, and Web of Science were searched for "generic drug name" AND "alopecia" and "generic drug name" AND "hair loss." Two reviewers independently reviewed articles for drug, study type and level of evidence, and number of alopecia cases. RESULTS: A total of 192 unique drugs were investigated, with 110 yielding positive search results. Of these, 13 were associated with alopecia in studies with strong levels of evidence (adalimumab, infliximab, budesonide, interferon β-1α, tacrolimus, enoxaparin, zoster vaccine, lamotrigine, docetaxel, capecitabine, erlotinib, imatinib, and bortezomib). LIMITATIONS: Only full-length articles available in the English language were included. The methodology used relied on lists of drugs based on their sales rather than number of prescriptions, which likely overrepresented expensive drugs. CONCLUSIONS: Few studies with high levels of evidence have been conducted on the topic of medication-associated alopecia. The mechanisms of hair loss must be further identified to provide effective management.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Mounessa J, Caravaglio JV, Domozych R, et al. Commonly prescribed medications associated with alopecia. J Am Acad Dermatol. 2023. PMID: 37268392. doi:10.1016/j.jaad.2017.01.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。